Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 370

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

High complement levels in astrocyte‐derived exosomes of Alzheimer disease

Open access
Goetzl, Edward J., Schwartz, Janice B., Abner, Erin L., Jicha, Gregory A., Kapogiannis, Dimitrios · 2018 · Annals of Neurology

Abstract

Objective: Astrocytes fulfill neuronal trophic roles normally, but are transformed in Alzheimer disease (AD) into A1‐type reactive astrocytes that may destroy neurons through unknown mechanisms. Methods: To investigate astrocyte inflammatory mechanisms, astrocyte‐derived exosomes (ADEs) were isolated immunochemically from plasma samples of AD patients and matched controls for enzyme‐linked immunosorbent assay quantification of complement proteins. Results: ADE levels of C1q, C4b, C3d, factor B, factor D, Bb, C3b, and C5b‐C9 terminal complement complex, but not mannose‐binding lectin, normalized by the CD81 exosome marker were significantly higher for AD patients (n = 28) than age‐ and gender‐matched controls (all p < 0.0001). ADE normalized levels of interleukin (IL)‐6, tumor necrosis factor‐α, and IL‐1β were significantly higher for AD patients than controls, but there was greater overlap between the two groups than for complement proteins. Mean ADE levels of complement proteins for AD patients in a longitudinal study were significantly higher (n = 16, p < 0.0001) at the AD2 stage of moderate dementia than at the AD1 preclinical stage 5 to 12 years earlier, which were the same as for controls. ADE levels of complement regulatory proteins CD59, CD46, decay‐accelerating factor (DAF), and complement receptor type 1, but not factor I, were significantly lower for AD patients than controls (p < 0.0001 for CD59 and DAF), were diminished by the AD1 stage, and were further decreased at the AD2 stage. Interpretation: ADE complement effector proteins in AD are produced by dysregulated systems, attain higher levels than in controls, and may potentially damage neurons in the late inflammatory phase of AD. Ann Neurol 2018;83:544–552

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.25172

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 370

Metadata

Authors
Goetzl, E. J., Schwartz, J. B., Abner, E. L., Jicha, G. A., & Kapogiannis, D.
Venue
Annals of Neurology
Publisher
Wiley
Published
2018-03
Volume
83
Issue
3
Pages
544-552
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2790294879
Cited by
370
References
34
FWCI
21.82
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High complement levels in astrocyte‐derived exosomes of Alzheimer disease. https://app.cochat.ai/papers/10.1002/ana.25172
The paper
Goetzl, E. J., Schwartz, J. B., Abner, E. L., Jicha, G. A., & Kapogiannis, D. (2018). High complement levels in astrocyte‐derived exosomes of Alzheimer disease. Annals of Neurology. https://doi.org/10.1002/ana.25172

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.